Home›Grant Finder›Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
Sponsored by National Institutes of Health
Award
Varies — see funder site
Deadline
October 15, 2027
Geography
Open nationwide
Eligible organization types
Open to most organization types — confirm on funder site.